Ursodeoxycholic Acid Inhibits Inflammatory Responses and Promotes Functional Recovery After Spinal Cord Injury in Rats

[1]  Soo-Hong Lee,et al.  Matrix Metalloproteinase-8 Inhibition Prevents Disruption of Blood–Spinal Cord Barrier and Attenuates Inflammation in Rat Model of Spinal Cord Injury , 2017, Molecular Neurobiology.

[2]  I. Han,et al.  Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury , 2017, Molecular Neurobiology.

[3]  Sung Jun Kim,et al.  Anti-inflammatory effects of ursodeoxycholic acid by lipopolysaccharide-stimulated inflammatory responses in RAW 264.7 macrophages , 2017, PloS one.

[4]  Hariprakash Haragopal,et al.  An efficient device to experimentally model compression injury of mammalian spinal cord , 2015, Experimental Neurology.

[5]  S. Chaki,et al.  Differential effects of NMDA receptor antagonists at lower and higher doses on basal gamma band oscillation power in rat cortical electroencephalograms , 2014, Neuropharmacology.

[6]  Y. Ohkawa,et al.  Ly6C+Ly6G− Myeloid‐derived suppressor cells play a critical role in the resolution of acute inflammation and the subsequent tissue repair process after spinal cord injury , 2013, Journal of neurochemistry.

[7]  M. Zheng,et al.  Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis , 2012, Molecular Biology Reports.

[8]  Yu-fei Chen,et al.  Tanshinone IIA Attenuates the Inflammatory Response and Apoptosis after Traumatic Injury of the Spinal Cord in Adult Rats , 2012, PloS one.

[9]  A. Shunmugavel,et al.  The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury. , 2010, The American journal of pathology.

[10]  T. Woodruff,et al.  Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. , 2010, Brain : a journal of neurology.

[11]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[12]  E. Mazzon,et al.  Evidence for the Role of Mitogen-Activated Protein Kinase Signaling Pathways in the Development of Spinal Cord Injury , 2008, Journal of Pharmacology and Experimental Therapeutics.

[13]  P. Popovich,et al.  Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury , 2008, Experimental Neurology.

[14]  Tony J Collins,et al.  ImageJ for microscopy. , 2007, BioTechniques.

[15]  David A Ramsay,et al.  The cellular inflammatory response in human spinal cords after injury. , 2006, Brain : a journal of neurology.

[16]  Fred H. Gage,et al.  Therapeutic interventions after spinal cord injury , 2006, Nature Reviews Neuroscience.

[17]  M. Sipski,et al.  High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients , 2005, Spinal Cord.

[18]  M. Beattie.  Inflammation and apoptosis: linked therapeutic targets in spinal cord injury. , 2004, Trends in molecular medicine.

[19]  M. Schwab,et al.  Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays , 2003, Trends in Neurosciences.

[20]  O N Hausmann,et al.  Post-traumatic inflammation following spinal cord injury , 2003, Spinal Cord.

[21]  L. Noble,et al.  Matrix Metalloproteinases Limit Functional Recovery after Spinal Cord Injury by Modulation of Early Vascular Events , 2002, The Journal of Neuroscience.

[22]  G. Gores,et al.  Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. , 2001, Journal of hepatology.

[23]  Gyeong-Moon Kim,et al.  Glucocorticoid Receptor-Mediated Suppression of Activator Protein-1 Activation and Matrix Metalloproteinase Expression after Spinal Cord Injury , 2001, The Journal of Neuroscience.

[24]  E. Senba,et al.  Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. , 2000, Journal of neurotrauma.

[25]  M. C. Acosta,et al.  Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. , 1999, Journal of neurotrauma.

[26]  J. Deleo,et al.  Acute peripheral inflammation induces moderate glial activation and spinal IL-1β expression that correlates with pain behavior in the rat 1 Published on the World Wide Web on 17 March 1999. 1 , 1999, Brain Research.

[27]  J. Boyer,et al.  Ursodeoxycholic acid in cholestasis: Potential mechanisms of action and therapeutic applications , 1998, Hepatology.

[28]  J. L. Rodriguez,et al.  Consequences of high-dose steroid therapy for acute spinal cord injury. , 1997, The Journal of trauma.

[29]  M. Schwab,et al.  Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat , 1995, Brain Research.

[30]  D. Basso,et al.  A sensitive and reliable locomotor rating scale for open field testing in rats. , 1995, Journal of neurotrauma.

[31]  F. Zwas,et al.  Ursodeoxycholic acid in the treatment of chronic liver disease. , 1994, The American journal of gastroenterology.

[32]  A. Hofmann,et al.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis part II , 1982, Digestive Diseases and Sciences.

[33]  A. Nilsson,et al.  Ursodeoxycholic acid increases the activities of alkaline sphingomyelinase and caspase-3 in the rat colon. , 1999, Scandinavian journal of gastroenterology.